Hemispherx Biopharma: Wilder and Wilder

A few weeks ago, we wrote Hemispherx Biopharma’s (HEB – $2.73) shares were on a rollercoaster and it seems the ride is getting wilder and wilder.

Obviously, there’s a tremendous amount of speculation about the FDA’s decision to approve Ampligen for Chronic Fatigue Syndrome (CFS). Based on all the public information out there, you have to form an opinion, and we believe Ampligen has a fair chance to be approved.

Also feeding the speculation, was Hemispherx’ press release on Thursday about the publication of an article in Therapeutics and Clinical Risk Management. The article summarizes ongoing research in which researchers conclude that Ampligen is the “most promising adjuvant candidate for mucosal vaccines.” The article further stated that Ampligen was also “extremely important” in these studies, in that it produced cross-protection against variant influenza viruses not seen with the vaccines given alone.

Simply terrific news we believe, and another indication that Ampligen can be used to combat various diseases.


We also had a couple of publications by “journalist” Adam Feuerstein from Thestreet.com. We emphasize journalist, because according to Wikipedia the definition of a journalist is: “A person who practices journalism, the gathering and dissemination of information about current events, trends, issues, and people while striving for viewpoints that aren’t biased.”

We guess Mr. Feuerstein forgot about that last sentence in his latest articles. In his first piece he wrote: “In fact, Hemispherx reminds me so much of Biopure (BPUR), the old human blood substitute company. That story ended badly, and so will Hemispherx.” And in his second one he wrote : “… you get the picture of a company desperately trying to pump up its stock price before the FDA rejects Ampligen.”

That isn’t objective an unbiased, in fact Wikipedia also has a definition for this kind or reporting: gutter journalism.

Undoubtedly, Hemispherx could take legal action against Thestreet.com for spreading misleading information, but I would prefer them to concentrate their time and energy on moving the business forward.

When we recommended the Company in January, its shares were trading at 36 cents. If you bought back then, you have a 750% return. If you are afraid to loose some or all of those gains, we advice you to sell on Monday. After all, it doesn’t happen every day you can sell at such a nice profit.

However, if your stomach can stand the rollercoaster ride (like ours can), hang in there and wait for the FDA’s decision.

Photo credit marada

Today's Best Small Cap Stock Ideas
1. I like Acme United because it’s fundamentally sound with over $63 million dollars in sales and $2.5 million dollars in earnings in 2010. At the same time I expect the Company to grow substantially over the next few years as it’s bringing incomparable (really!) cutting products to the market. Download your copy of the latest Company Report.
2. Global Green Solutions Inc. is developing Greensteam; a commercial-stage, high-efficiency combustion system that generates industrial steam and electrical power from waste biomass. Read our latest updates on Global Green Solutions.
3. NSGold Corporation is a Canadian junior mining company that focuses on transforming advanced exploration opportunities into a mid tier gold producer. Read our latest Company Report on NSGold Corp.

  • Great article, and an excellent inclination on uncovering the term, “Gutter Journalism”

    – M V

  • HEB follower since ’04. Both times AF released his view, the stock started selling within minutes. The 1st fell off and then went back up later that day. However, this last one struck a nerve with some folks. The most negative thing I have seen is the BONUSES upper mgt. gave themselves as soon as they firmed the stock deal. If you are raising capital for the company, you don’t give it away the next day. Plus, they added some dilution to HEB holders.

  • It’s really only “yellow journalism” if he has no facts, or least what he believes to be facts to back up his statements.

    “Journalists” offer opinions everyday in the form of editorials. Not all editorials are “unbiased.”

  • A letter will be sent as early as Monday pre-market with copies sent to all major news networks worldwide in which investors will be taking on the SEC, FTC and the Office of the President challenging them to reply. It will cover possible stock manipulation and back door disbursement of profits, specific to recent activity of The Street.com and its contributors, namely Adam Feuerstein who was instrumental in using public media and the internet to transmit false reports on several Bio stocks. It should be known that price drop and hedge fund purchases mysteriously coincided with the drops and immediately followed the post articles on The Street.com website. Specific to the demand for a public reply is as follows: Why did monitoring agencies question the CEO of Hemispherx Bio (HEB) about the sudden rise in stock price 8 days ago, while when the stock experienced a loss at greater than that rise rate, did not question the “reporter” at The Street.com as to their involvement in possible short selling, hedge fund involvement and price manipulation. Ironically Jim Cramer has recently begun a formal “short selling” petition that he publicly touted on his Mad Money CNBC show. Is this a ploy to mask his own activity and those of his financial circles to hide behind? ( see video for reference http://www.youtube.com/watch?v=HRa0B34jM… The clips seemed to strike a sour tone to CNBC and many of the clips were removed. Is CNBC actively aware of background manipulation tactics used by The Street and many who are within their circles? Could it be very possible that stock manipulation goes further than the halls of wall street and those involved were able to get embedded deep into the SEC and FTC so that only the privileged who hide behind the “Freedom of Speech” clause can avoid prosecution? It is time that the oval office become more aware of issues that go further than the political sectors and begin cleaning house where it’s needed. I say, yes, Mr. President, I will challenge you as well to reply to me via this board. Your platform is change; I myself voted for you and have no fear of making that public. I too see the future as one that requires change, and not only from the bottom up but also from the top down. My goal on Monday will be to make these challenges very public in whatever means it takes to achieve it. If it means that entities and individuals and The Street.com become the pinnacle of an in-depth investigation, so be it. It is owed to the American people for the President to become responsive to issues that make a difference to all people in America, regardless of class, celebrity status, or political affiliation. To this end, I will see that this exercise does not fall on deaf ears and mark my words, these events will be investigated and should Adam Feuerstein or Mr. Cramer be found guilty of any charges on a federal level it would be incumbent on all who have experienced financial losses to bring charges against these same individuals and the vehicles of media they are employed by, specifically NBC, GE (Owner of NBC and its affiliates. This notion is made on the basis that enough posts were made on this and other financial boards to make it so that CNBC and other management of NBC affiliated media sources were apprised of possible illegal movement within their organization and if it was not addressed or can be proved to have been addressed, that NBC and its owners and affiliates will be held liable for the compensation of all losses to shareholders and be held accountable for and not limited to criminal and civil penalties. Copy and communicate this release to as many of the boards or media sources that you are associated with on or before Monday. Thank you all in advance for your support and hope that we can begin to rid Wall street of criminals who are at the forefront of the corruption that helped put the United States in the unwanted financial crisis we are all experiencing.

  • Please request SEC investigation on TheStreet.com, namely Adam Feuerstein’s biased articles on Biomedical companies such as HEB. Your concerns will help us enforce the rule of law and slam backdoors to potential swindlers. Please do as soon as possible, do not delay.

    Here is SEC’s info
    (202) 551-8090, by fax at (202) 772-9295,

  • Adam’s influence, if any, is on small (retail) investors. What happened on 6/4 and 6/5 was an orchestrated maneouver by big investors to manipulate the price. HEB’s short interest is ~1 day, let’s not forget that! That volume could not be achieved by retail traders alone IMHO. We should not be giving Adam credit for any of that.

Leave a Reply

Your email address will not be published.